Get started
Author

Sarah E. Ackermann

Deletions linked to TP53 loss drive cancer through p53-independent mechanisms
2016 · Yu Liu, Chong Chen, et al. · Nature · 278
Extracellular Matrix in Synthetic Hydrogel‐Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors
2021 · Matthew J. Mosquera, Sungwoong Kim, et al. · Advanced Materials · 76
Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer
2025 · Jonathan M. DeLiberty, Mallory K. Roach, et al. · Cancer Research · 22
Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition
2025 · Florencia P. Madorsky Rowdo, Rachel Martini, et al. · Cancer Research · 19
PDF
CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer
2025 · Szu-Aun Long, Haley Todd, et al. · Cancer Research · 7
Extracellular Matrix in Synthetic Hydrogel‐Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors (Adv. Mater. 2/2022)
2022 · Matthew J. Mosquera, Sungwoong Kim, et al. · Advanced Materials · 6
Novel co-culture strategies of tumor organoids with autologous T-cells reveal clinically relevant combinations of immune-checkpoint and targeted therapies
2023 · Enrique Podaza, Jared Capuano, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5
PDF
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities
2026 · Hui-Hsuan Kuo, Bhavneet Bhinder, et al. · Science Advances · 1
PDF
Data from CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer
2026 · Szu-Aun Long, Haley Todd, et al. · 1
Kinome focused CRISPR-Cas9 screens in African ancestry patient-derived breast cancer organoids identify essential kinases and synergy of EGFR and FGFR1 inhibition
2024 · M. Laura Martin, Rachel Martini, et al. · Research Square · 1
PDF
Abstract A047: Mechanistic dissection and inhibitor targeting of nutrient scavenging in pancreatic cancer
2026 · Sarah E. Ackermann, Seamus E. Degan, et al. · Cancer Research
Survivin Promotes the Formation of a Microtubule-Based Glycolytic Hub
2026 · Jacob Neumann, Wen-Hsuan Chang, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Figure 1 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling
2026 · Ryan Robb, Sarah E. Ackermann, et al.
Figure 3 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling
2026 · Ryan Robb, Sarah E. Ackermann, et al.
Figure 4 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling
2026 · Ryan Robb, Sarah E. Ackermann, et al.
Figure S1 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling
2026 · Ryan Robb, Sarah E. Ackermann, et al.
Figure 5 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling
2026 · Ryan Robb, Sarah E. Ackermann, et al.
Figure 6 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling
2026 · Ryan Robb, Sarah E. Ackermann, et al.
Figure S9 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling
2026 · Ryan Robb, Sarah E. Ackermann, et al.
Figure S11 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling
2026 · Ryan Robb, Sarah E. Ackermann, et al.
Figure S2 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling
2026 · Ryan Robb, Sarah E. Ackermann, et al.
Figure S8 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling
2026 · Ryan Robb, Sarah E. Ackermann, et al.
Figure S13 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling
2026 · Ryan Robb, Sarah E. Ackermann, et al.
Figure S7 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling
2026 · Ryan Robb, Sarah E. Ackermann, et al.
Figure S6 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling
2026 · Ryan Robb, Sarah E. Ackermann, et al.
Works count: 117
Citation count: 416
H-index: 6
I10-index: 4
Year
Topic
Type